About Biosynth Carbosynth
Biosynth Carbosynth is a company based in Guildford (United Kingdom) founded in 1965 was acquired by KKR in November 2021.. Biosynth Carbosynth has completed 2 acquisitions, including Aalto Bio Reagents and vivitide. Biosynth Carbosynth operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Curia and AmplifyBio, among others.
- Headquarter Guildford, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biosynth Limited
- Date of Incorporation 06 Apr, 2006
- Jurisdiction NEWBURY, BERKSHIRE
-
Annual Revenue
$23.11 M (USD)-8as on Dec 31, 2020
-
Net Profit
$950.18 K (USD)910as on Dec 31, 2020
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Aalto Bio Reagents
& 1 more
-
Acquired by
KKR
(Nov 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biosynth Carbosynth
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biosynth Carbosynth
Biosynth Carbosynth has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include KKR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biosynth Carbosynth
Biosynth Carbosynth has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Aalto Bio Reagents and vivitide. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug development services for neoantigen peptides and antibodies are provided.
|
1983 | ||||
|
Raw materials are supplied to in-vitro diagnostics and research laboratories.
|
1978 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biosynth Carbosynth
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biosynth Carbosynth Comparisons
Competitors of Biosynth Carbosynth
Biosynth Carbosynth operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Curia and AmplifyBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| domain | founded_year | HQ Location |
CDMO offering drug and biologics development services
|
|
| domain | founded_year | HQ Location |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| domain | founded_year | HQ Location |
Drug research, development, testing, and consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Provides contract research, development, and manufacturing services for biologic drugs.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing for biologics are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biosynth Carbosynth
Frequently Asked Questions about Biosynth Carbosynth
When was Biosynth Carbosynth founded?
Biosynth Carbosynth was founded in 1965.
Where is Biosynth Carbosynth located?
Biosynth Carbosynth is headquartered in Guildford, United Kingdom.
Who is the current CEO of Biosynth Carbosynth?
Urs Spitz is the current CEO of Biosynth Carbosynth.
What is the annual revenue of Biosynth Carbosynth?
Annual revenue of Biosynth Carbosynth is $23.11M as on Dec 31, 2020.
What does Biosynth Carbosynth do?
Biosynth Carbosynth was established in 1965 and is headquartered in Guildford, United Kingdom. Operations focus on the pharmaceutical and chemical sectors, where drug discovery, manufacturing, supply chain management, and regulatory support services are delivered. Additional services encompass product synthesis and customization for research and industrial applications. The company serves global clients through its integrated facilities and expertise in complex molecule production.
Who are the top competitors of Biosynth Carbosynth?
How many acquisitions has Biosynth Carbosynth made?
Biosynth Carbosynth has made 2 acquisitions, including Aalto Bio Reagents, and vivitide.
Who are Biosynth Carbosynth's investors?
Biosynth Carbosynth has 1 investor. Key investors include KKR.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.